DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc.
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 3
Financing history
1 rounds
- Apr 24, 2024Form D equity offering · $240M (form d sold) · 7 investorsFact SEC EDGAR Form D data sets (quarterly) · “Cidara Therapeutics, Inc. filed Form D: $240,000,000 sold of $240,000,000, Biotechnology”
Investors on record
3 edges
- RA Capital Management, LP portfolio listing Fact racap.com
- Vivo Capital, LLC portfolio listing Fact vivocapital.com
- Omega Fund Management, LLC portfolio listing Fact omegafunds.com
People
5 officers, 7 directors
- Jeffrey Stein, PH.D. Executive Officer/Director sec.gov
- Leslie R. Tari, PH.D. Executive Officer sec.gov
- Preetam R. Shah, PH.D. Executive Officer sec.gov
- Shane R. Ward Executive Officer sec.gov
- Taylor R. Sandison, M.D. Executive Officer sec.gov
- Carin R. Canale-Theakston Director Fact
- Theodore R. Schroeder Director Fact
- Daniel D Burgess Director Fact
- Laura R. Tadvalkar, PH.D. Director Fact
- Bonnie R. Bassler, PH.D. Director Fact
- James R. Merson, PH.D. Director Fact
- Ryan R. Spencer Director Fact
Timeline
2
- Sep 16, 2026Cidara Therapeutics, Inc. no longer listed on Omega Fund Management, LLC's portfolio pageRemoved from portfolio page Inference Venture organization websites (about, team, portfolio, thesis, news pages)
- May 6, 2024Cidara Therapeutics, Inc. filed Form D: $240,000,000 sold of $240,000,000, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
18 observations
Every observation on this company
- Entity type: Corporation May 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology May 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false May 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose May 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears May 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE May 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $240M May 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $240M May 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b May 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2024-04-24 May 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 7 May 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 May 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity May 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 6310 NANCY RIDGE DRIVE, SUITE 101, SAN DIEGO, CA, 92121 May 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Listed on portfolio page: RA Capital Management, LP Sep 16, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: Vivo Capital, LLC Sep 16, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: RA Capital Management, LP Sep 15, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: Omega Fund Management, LLC Sep 13, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)